Epitaz 50mg Injection

Prezentare produs

About Epitaz

Epitaz is a medication containing the active ingredient Epirubicin. Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE ELLENCE is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Epirubicin, the active ingredient in Epitaz, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE ELLENCE is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer [see Clinical Studies (14. 1) ] . Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Epitaz. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Epitaz for extended periods without medical advice.